CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-09 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $32.54 | $81K | 0 |
| 2019-01-09 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 4,890 | ||
| 2019-01-08 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-08 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $32.31 | $81K | 0 |
| 2019-01-08 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 7,390 | ||
| 2019-01-07 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-07 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $32.21 | $81K | 0 |
| 2019-01-07 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 9,890 | ||
| 2019-01-04 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-04 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $31.30 | $78K | 0 |
| 2019-01-04 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 12,390 | ||
| 2019-01-03 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-03 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $31.72 | $79K | 0 |
| 2019-01-03 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 14,890 | ||
| 2018-11-01 | Warras Dean J Pres Animal Health & Nutr N.A. | Option exercise | +10,000 | $11.83 | $118K | 10,000 |
| 2018-11-01 | Warras Dean J Pres Animal Health & Nutr N.A. | Sale | −9,800 | $42.83 | $420K | 9,800 |
| 2018-11-01 | Warras Dean J Pres Animal Health & Nutr N.A. | Sale | −200 | $43.40 | $9K | 0 |
| 2018-11-01 | Warras Dean J Pres Animal Health & Nutr N.A. | Option exercise · Option to purchase Class A Common Stock | −10,000 | 1,670 | ||
| 2018-09-12 | BFI Co., LLC 10% owner | Conversion | +30,000 | 60,000 | ||
| 2018-09-12 | BFI Co., LLC 10% owner | Sale | −520 | $45.04 | $23K | 59,480 |
Page 12 of 18 · 343 trades